Larvol Delta - AffyImmune-Therapeutics-Announces-First-Patient-Enrolled-in-Phase-I-Clinical-Trial-of-AIC100-CAR-T-cells-for-the-Treatment-of-Advanced-Refractory-Thyroid-Cancer

AIC100 - AffyImmune Therap

https://www.prnewswire.com/news-releases/affyimmune-therapeutics-announces-first-patient-enrolled-in-phase-i-clinical-trial-of-aic100-car-t-cells-for-the-treatment-of-advanced-refractory-thyroid-cancer-301162686.html

Oct 29, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next